This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Oncology Podcasts

Episode 2

Xofigo

Optimising patient identification and referral — Xofigo
®
(radium-223 dichloride)

Description

Hear from the perspective of both a leading oncologist and nuclear medicine consultant how they optimise the treatment and referral pathway for their patients.

Speakers:

  • Dr Julia Murray
     - Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust
  • Dr Amy Eccles
     - Consultant Radionuclide Radiologist and Clinical Lead, The London Clinic

 

This promotional podcast series has been initiated and funded by Bayer and is for healthcare professionals only.

Speakers

Prostate Cancer Podcast Episode 3
Episode 3 | The Practicalities of Treatment
Xofigo® (radium-223 dichloride)
PP-XOF-GB-0681, September 2025
Prostate Cancer Podcast Episode 1
Episode 1 | Why treat with
Xofigo® (radium-223 dichloride)
PP-XOF-GB-0679, September 2025

PP-XOF-GB-0680 | September 2025